Pfizer bought Global Blood Therapeutics Global Blood Therapeutics from 10/5/22

User image

Vladimir Petenev

News editor
press@blackterminal.com

Pfizer completed its acquisition of Global Blood Therapeutics for $5.4, or $68.5 per share.

Global Blood Therapeutics

Review

Source:

{source} pictogram

investors.pfizer.com

Vladimir Petenev

News editor

Write your comment first

News feed

Exalter has announced a Pre-IPO on MOEX Startup

1/21/25 OTCI

Zymer's issuance volume in 2024 was a record ₽56 billion

1/21/25 ZAYM

RuStore became second in popularity to Google Play

1/21/25 VKCO

Etalon Group's sales for 2024 grew by 28%

1/21/25 ETLN

Bank of Russia intends to increase transparency of IPO

1/20/25 MOEX

Promomed plans to enter the Iraqi market

1/20/25 PRMD

Rusagro will start building a butter plant in Kuzbass in 2025

1/20/25 AGRO

Acron's core product output remained at the same level as last year

1/20/25 AKRN

Novatek reduced the construction period of the Murmansk LNG by three years

1/20/25 NVTK

Magnit opened a store M City in foodmall Three Vokzala. Depot

1/20/25 MGNT